T-cell receptor β variable region diversity in melanoma metastases after interleukin 2-based immunotherapy

Clinical Cancer Research

Volumn 2, Issue 4, 1996, Pages 767-772

  Willhauck, Martina ^a   Möhler, Thomas ^a   Scheibenbogen, Carmen ^a   Pawlita, Michael ^b   Brossart, Peter ^a   Schmier, Johann W ^a   Keilholz, Ulrich ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; INTERLEUKIN 2; T LYMPHOCYTE RECEPTOR;

ARTICLE; CANCER IMMUNOTHERAPY; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; MELANOMA; METASTASIS; PRIORITY JOURNAL;

HUMANS; IMMUNOTHERAPY; INTERLEUKIN-2; KILLER CELLS, LYMPHOKINE-ACTIVATED; LYMPHOCYTES, TUMOR-INFILTRATING; MELANOMA; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; REPRODUCIBILITY OF RESULTS;

EID: 0029988209     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Kawakami, Y., Zakut, R., Topalian, S. L., Stotter, H., and Rosenberg, S. A. Shared human melanoma antigens. Recognition by tumor infiltrating lymphocytes in HLA-A2.1 transfected melanomas. J. Immunol., 148: 638-643, 1992.
2. Itoh, K., Platsoucas, P. D., and Balch, C. M. Autologous tumor specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. J. Exp. Med., 168: 1419-1442, 1988.
3. Wölfel, T., Klehmann, E., Müller, C., Schutt, K. H., Meyer zum Buschenfelde, K. H., and Knuth, A. Lysis of human melanoma cells by autologous cytolytic T cell clones: identification of human histocompatibility leucocyte antigen A2 as a restriction element for three different antigens. J. Exp. Med., 170: 797-810, 1989.
4. Schöller, J., thor Straten, P., Birck, A., Siim, E , Dahlström, K., Drewiecki, K. T., and Zeuthen, J. Analysis of T cell receptor αβ variability in lymphocytes infiltrating melanoma primary tumors and metastatic lesions. Cancer Immunol. Immunother., 39: 239-248, 1994.
5. Mackensen, A., Carcelain, G., Viel, S., Raynal, M.-C., Michalaki, H , Triebel, F., Bosq, J., and Hercend, T. Direct evidence to support the immunosurveillance concept in a human regressive melanoma. J. Clin. Invest., 93: 1397-1402, 1994.
6. Sensi, M., Salvi, S., Castelli, C., Macalli, C., Mazzocchi, A., Mortarini, R., Nicolini, G., Herlyn, M., Parmiani, G., and Anichini, A. T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor infiltrating lymphocytes overexpress in vivo the TCR β chain sequence used by an HLA-A2 restricted and melanocyte-lineage-specific CTL clone. J. Exp. Med., 178: 1231-1246, 1993.
7. Weidmann, E., Elder, E. M., Trucco, M., Lotze, M. T., and Whiteside, T. L. Usage of T cell receptor Vβ chain genes in fresh and cultured tumor-infiltrating lymphocytes from human melanoma. Int. J. Cancer, 54: 383-390, 1993.
8. Keilholz, U., Scheibenbogen, C., Tilgen, W., Bergmann, L., Weidmann, E., Seither, E., Richter, M., Brado, B., Mitrou, P. S., and Hunstein, W. IFNα and IL-2 in the treatment of metastatic melanoma: comparison of two phase II trials. Cancer (Phila.), 72: 607-614, 1993.
9. Keilholz, U., Scheibenbogen, C., Brado, M., Georgi, P., Maclachlan, D., Brado, B., and Hunstein, W. Regional adoptive immunotherapy with IL-2 and lymphokine-activated killer (LAK) cells for liver metastases. Eur. J. Cancer, 30A: 103-105, 1994.
10. Keilholz, U., Scheibenbogen, C., Stoelben, E., Saeger, H. D., and Hunstein, W. Immunotherapy of metastatic melanoma with interferon-α and interleulan-2: pattern of progression in responders and patients with stable disease with or without resection of residual lesions. Eur. J. Cancer, 30A: 955-958, 1994.
11. Chomczynski, P., and Sacchi, N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
12. Möhler, T., Willhauck, M , Scheibenbogen, C., Pawlita, M., Brossart, P., and Keilholz, U. T-cell recptor Vα/β usage of tumor infiltrating T cells in primary, regressing and progressing melanoma metastases following immunotherapy with IFNα and IL2: evidence for a specific T-cell response Melanoma Res., 2: 129-132, 1995.
13. Choi, Y., Kotzin, B., Herron, L., Callahan, J., Marrack, P., and Kappler, J. Interaction of Staphylococcus aureus toxin "superantigens" with human T cells. Proc. Natl. Acad Sci., USA, 86: 8941-8945, 1989.
14. Church, M. G., and Gilbert, W. Genomic sequencing. Proc. Natl. Acad. Sci. USA, 81: 1991-1995, 1984.
15. Slingluff, C., Cox, A. L., Henderson, R. A., Hunt, D. F., and Engelhard, V. H. Recognition of human melanoma cells by HLA-A2.1-restricted cytotoxic T lymphocytes is mediated by at least six shared peptide epitopes. J. Immunol., 150: 2955-2963, 1993.
16. Kawakami, Y., Eliyami, S., Sakaguchi, K., Robbins, P. F., Rivoltini, L., Yanelli, J. R., Apella, E., and Rosenberg, S. A. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J. Exp. Med., 180: 347-352, 1994.
17. Cox, A. L., Skipper, J., Chen, Y., Hendersen, R. A., Darrow, T. L., Shabanowitz, J., Engelhard, V. H., Hunt. D. F., and Slingluff, C. L. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines Science (Washington DC), 264: 716-719, 1994.
18. Chien, Y., and Davis, M. M. How αβ T-cell receptors see peptide/ MHC complexes. Immunol. Today, 14: 597-602, 1993.
19. Cole, D. J., Weil, D. P., Shamamian, P., Rivoltini, L., Kawakami, Y., Topalian, S., Jennings, C., Eliyahu, S., Rosenberg, S. A., and Nishimura, M. I. Identification of MART-1-specific T-cell receptors: T cells utilizing distinct T-cell receptor variable and joining regions recognize the same tumor epitope. Cancer Res., 54: 5265-5268, 1994.
20. Rammensee, H-G., Friede, T., and Stefanovic, S. MHC ligands and peptide motifs: first listing. Immunogenetics, 41: 178-228, 1995.
21. Puisieux, I., Even, J., Pannetier, C., Jotereau, F., Favrot, M., and Kourilsky, P. Oligoclonality of tumor-infiltrating lymphocytes from human melanomas. J. Immunol., 153: 2807-2818, 1994.
22. Ferradini, L., Roman-Roman, S., Azocar, J., Avril, M-F., Viel, S., Triebel, F., and Hercend, T. Analysis of T-cell receptor α/β variability in lymphocytes infiltrating a melanoma metastasis. Cancer Res., 52: 4649-4654, 1992.
23. Sensi, M., Castelli, C., Anichini, A., and Grossberger, D. Two autologous melanoma specific and MHC restricted human T cell clones with identical intra-tumor reactivity do not share the same TCR Vα and β gene families. Melanoma Res., 194: 261-271, 1991.
24. Pannetier, C., Even, J., and Kourilsky, P. T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol. Today, 16: 176-181, 1995.
25. Shilyanski, J., Nishimura, M. I., Yanelli, J. R., Kawakami, Y., Jacknin, L. S., Charmley, P., and Rosenberg, S. A. T-cell receptor usage by melanoma-specific clonal and highly oligoclonal tumor infiltrating lymphocytes lines. Proc. Natl. Acad. Sci. USA. 91: 2829-2833, 1994.
26. Sensi, M., Traversari, C., Radrizzani, M., Salvi, S., Maccalli, C., Mortarini, R., Rivoltini, L., Farina, C., Nicolini, G., Wölfel, T., Brichard, V., Boon, T., Bordignon, C., Anichini, A., and Parmiani, G. Cytotoxic T-lymphocyte clone from different patients display limited T-cell-receptor variable-region gene usage in HLA-A2 restricted recognition of the melanoma antigen Melan-A/MART-1. Proc. Natl. Acad. Sci. USA, 92: 5674-5678, 1995.